EXE vs. DNTL, SIA, WELL, DR, KDA, NLH, PHA, BHC, BLU, and TRIL
Should you be buying Extendicare stock or one of its competitors? The main competitors of Extendicare include dentalcorp (DNTL), Sienna Senior Living (SIA), WELL Health Technologies (WELL), Medical Facilities (DR), KDA Group (KDA), Nova Leap Health (NLH), Premier Health of America (PHA), Bausch Health Companies (BHC), BELLUS Health (BLU), and Trillium Therapeutics (TRIL). These companies are all part of the "medical" sector.
Extendicare vs.
dentalcorp (TSE:DNTL) and Extendicare (TSE:EXE) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.
Extendicare has lower revenue, but higher earnings than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.
Extendicare received 116 more outperform votes than dentalcorp when rated by MarketBeat users. However, 64.81% of users gave dentalcorp an outperform vote while only 47.34% of users gave Extendicare an outperform vote.
50.3% of dentalcorp shares are held by institutional investors. Comparatively, 19.2% of Extendicare shares are held by institutional investors. 0.2% of dentalcorp shares are held by insiders. Comparatively, 13.9% of Extendicare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Extendicare has a net margin of 4.48% compared to dentalcorp's net margin of -5.40%. Extendicare's return on equity of 64.13% beat dentalcorp's return on equity.
In the previous week, dentalcorp had 7 more articles in the media than Extendicare. MarketBeat recorded 10 mentions for dentalcorp and 3 mentions for Extendicare. dentalcorp's average media sentiment score of 0.70 beat Extendicare's score of 0.28 indicating that dentalcorp is being referred to more favorably in the media.
dentalcorp presently has a consensus target price of C$12.22, indicating a potential upside of 49.42%. Extendicare has a consensus target price of C$12.50, indicating a potential downside of 3.99%. Given dentalcorp's stronger consensus rating and higher probable upside, equities analysts plainly believe dentalcorp is more favorable than Extendicare.
dentalcorp has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Extendicare has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500.
Summary
dentalcorp beats Extendicare on 9 of the 17 factors compared between the two stocks.
Get Extendicare News Delivered to You Automatically
Sign up to receive the latest news and ratings for EXE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Extendicare Competitors List
Related Companies and Tools
This page (TSE:EXE) was last updated on 3/28/2025 by MarketBeat.com Staff